GO:0006111 regulation of gluconeogenesis: Metabolic Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006111 regulation of gluconeogenesis describes any process that modulates the frequency, rate or extent of glucose formation from noncarbohydrate precursors such as pyruvate, amino acids and glycerol.
• Hormonal control, especially by glucocorticoids and glucagon, is a central mechanism regulating gluconeogenic flux in liver and kidney.
• Key regulatory nodes include transcriptional coactivators such as PGC-1alpha, the acetyltransferase p300, and the deacetylase SIRT1, which integrate nutrient and hormonal signals.
• Natural small molecules, including flavonoids, can modulate gluconeogenesis at both pretranslational and posttranslational levels, offering therapeutic leads for metabolic disease.
• Gluconeogenesis regulation is conserved across tissues and species, from rodent liver to ovine skeletal muscle cells, enabling comparative and translational studies.
• Dysregulation of gluconeogenesis contributes to type 2 diabetes, obesity, and cancer metabolism, making it a high-value target for CRISPR-based functional genomics.
Description
Gluconeogenesis is the metabolic pathway that synthesizes glucose from noncarbohydrate precursors such as lactate, glycerol, and amino acids, and it is essential for maintaining blood glucose during fasting. The Gene Ontology term GO:0006111, regulation of gluconeogenesis, encompasses any process that modulates the frequency, rate, or extent of this pathway. Because gluconeogenesis is tightly controlled by hormones, nutrients, and cellular energy status, its regulation is a major focus in metabolic research. Understanding how gluconeogenesis is regulated has direct implications for diabetes, obesity, and cancer, where aberrant glucose production supports disease progression. This article synthesizes authoritative GO annotations and verified PubMed literature to provide a research-grade overview of GO:0006111, including its mechanisms, key genes, disease links, and experimental models.
regulation of gluconeogenesis At A Glance
| GO ID | GO:0006111 |
|---|---|
| GO term | regulation of gluconeogenesis |
| Ontology | biological_process |
| Synonym | regulation of gluconeogenesis involved in cellular glucose homeostasis; regulation of glucose biosynthesis; regulation of glucose biosynthetic process |
| Major function | Modulates the rate of glucose synthesis from noncarbohydrate precursors |
| Key regulators | Glucocorticoids, glucagon, insulin, PGC-1alpha, SIRT1, p300 |
| Tissues | Liver, kidney, skeletal muscle |
| Disease relevance | Type 2 diabetes, obesity, cancer, metabolic syndrome |
What Is GO:0006111?
GO:0006111 regulation of gluconeogenesis is defined as any process that modulates the frequency, rate or extent of gluconeogenesis, the formation of glucose from noncarbohydrate precursors, such as pyruvate, amino acids and glycerol. This term captures both positive and negative regulation, including hormonal, transcriptional, and posttranslational control mechanisms.
Why Is regulation of gluconeogenesis Important in Cell Biology?
Regulation of gluconeogenesis is critical for whole-body glucose homeostasis, and its dysregulation is a hallmark of metabolic diseases such as type 2 diabetes and obesity. The pathway is also hijacked in cancer to support tumor growth under nutrient-limited conditions. Because gluconeogenesis is controlled at multiple levels, from hormone signaling to chromatin modification, it serves as a paradigm for understanding how metabolic pathways are integrated with cellular signaling. Research on GO:0006111 therefore informs therapeutic strategies targeting glucose production in diabetes and cancer.
• Maintains blood glucose during fasting and starvation.
• Dysregulated in type 2 diabetes, contributing to hyperglycemia.
• Supports cancer cell proliferation under metabolic stress.
• Integrates hormonal signals (glucocorticoids, glucagon, insulin) with metabolic output.
• Involves epigenetic regulation via acetylation and deacetylation.
• Targeted by natural small molecules such as flavonoids for therapeutic benefit.
• Conserved across species, enabling translational studies in ovine and rodent models.
• Cross-talks with ketone body metabolism in kidney.
• Provides a model for studying pretranslational and posttranslational control.
• Offers opportunities for CRISPR-based functional genomics and drug discovery.
What Happens During regulation of gluconeogenesis?
Hormonal initiation of gluconeogenesis
In simple terms: Hormones like cortisol and glucagon tell the liver to start making glucose.
Glucocorticoids, such as cortisol, and glucagon are primary hormonal activators of gluconeogenesis during fasting. These hormones increase the transcription of gluconeogenic enzymes and coactivators, thereby enhancing glucose production from noncarbohydrate precursors. Insulin, in contrast, suppresses gluconeogenesis after feeding.
Transcriptional control of gluconeogenic genes
In simple terms: Special proteins turn on the genes needed to make glucose.
The transcriptional coactivator PGC-1alpha (PPARGC1A) is a master regulator of gluconeogenic gene expression, working with transcription factors such as FOXO1 and HNF4A. Glucocorticoid receptor and CREB also drive expression of key enzymes like PCK1 and G6PC. This transcriptional program is modulated by nutrient and energy sensors.
Posttranslational and epigenetic regulation
In simple terms: Chemical tags on proteins and DNA can fine-tune how fast glucose is made.
Acetylation and deacetylation of metabolic enzymes and histones regulate gluconeogenic flux. For example, the acetyltransferase p300 and deacetylase SIRT1 modulate the activity of PGC-1alpha and other regulators. Such posttranslational modifications allow rapid adaptation to changing metabolic demands.
Pretranslational regulation by natural small molecules
In simple terms: Certain natural compounds can change how much gluconeogenic protein is made.
Flavonoids and other natural small molecules can inhibit or activate gluconeogenesis by affecting mRNA stability, transcription, or translation of gluconeogenic genes. These compounds offer potential therapeutic avenues for modulating glucose production.
Inter-organ communication and ketone bodies
In simple terms: Different organs talk to each other to control glucose production.
Hepatic ketone bodies can regulate renal gluconeogenesis, illustrating cross-organ metabolic communication. This inter-organ regulation ensures coordinated glucose supply during prolonged fasting.
Key Genes Involved in GO:0006111 regulation of gluconeogenesis
The following genes and proteins are central to the regulation of gluconeogenesis, as supported by verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PCK1 | Rate-limiting enzyme in gluconeogenesis | Target for diabetes and cancer studies |
| G6PC | Catalyzes final step of gluconeogenesis | Mutations cause glycogen storage disease |
| PPARGC1A | Transcriptional coactivator driving gluconeogenic gene expression | Master regulator of metabolic adaptation |
| FOXO1 | Transcription factor activating gluconeogenic genes | Insulin signaling node |
| CREB | Transcription factor mediating glucagon signaling | Hormonal regulation |
| NR3C1 | Glucocorticoid receptor | Mediates glucocorticoid effects |
| SIRT1 | Deacetylase modulating PGC-1alpha activity | Epigenetic regulation |
| EP300 | Acetyltransferase modifying metabolic regulators | Posttranslational control |
| INSR | Insulin receptor | Suppresses gluconeogenesis |
| GCK | Glucokinase | Glucose sensing |
| FBP1 | Fructose-1,6-bisphosphatase | Gluconeogenic enzyme |
| GYS2 | Glycogen synthase | Glycogen storage |
| PDK4 | Pyruvate dehydrogenase kinase | Inhibits pyruvate oxidation |
| HNF4A | Hepatocyte nuclear factor 4 alpha | Transcriptional regulation |
| PPARA | Peroxisome proliferator-activated receptor alpha | Fatty acid oxidation and gluconeogenesis |
| CRTC2 | CREB-regulated transcription coactivator 2 | Hormonal regulation |
| KLF15 | Kruppel-like factor 15 | Amino acid catabolism and gluconeogenesis |
How Is regulation of gluconeogenesis Regulated?
Regulation of gluconeogenesis is controlled by a network of hormonal, nutritional, and epigenetic signals. Glucocorticoids and glucagon stimulate gluconeogenesis, while insulin suppresses it. At the transcriptional level, PGC-1alpha, FOXO1, and CREB coordinate the expression of gluconeogenic enzymes. Posttranslational modifications such as acetylation by p300 and deacetylation by SIRT1 fine-tune the activity of these regulators. Additionally, natural small molecules can modulate gluconeogenesis at pretranslational levels, offering pharmacological entry points. Inter-organ signals, including hepatic ketone bodies acting on renal gluconeogenesis, further refine this regulation.
regulation of gluconeogenesis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PCK1 | Type 2 diabetes, cancer | Liver-specific knockout mouse |
| G6PC | Glycogen storage disease type I | Point mutation knock-in |
| PPARGC1A | Obesity, insulin resistance | Overexpression in hepatocytes |
| NR3C1 | Cushing's syndrome, metabolic syndrome | Glucocorticoid receptor knockout |
| SIRT1 | Metabolic syndrome, aging | Deacetylase-deficient knock-in |
Type 2 diabetes and obesity
Excessive gluconeogenesis contributes to hyperglycemia in type 2 diabetes, and obesity-associated insulin resistance fails to suppress glucose production. Targeting regulators such as PGC-1alpha or glucocorticoid signaling is a therapeutic strategy.
Cancer metabolism
Cancer cells often rely on gluconeogenesis to support growth under nutrient-limited conditions, and its regulation is reprogrammed in tumors. Small molecule inhibitors of gluconeogenic regulators are being explored as anticancer agents.
Metabolic syndrome and kidney disease
Renal gluconeogenesis is regulated by ketone bodies and contributes to systemic glucose balance, with implications for diabetic kidney disease. Dysregulation of this cross-organ axis may exacerbate metabolic syndrome.
From regulation of gluconeogenesis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate gluconeogenesis? | CRISPR knockout in HepG2 or primary hepatocytes |
| Does a point mutation in gene Y alter enzyme activity? | CRISPR point mutation knock-in |
| Does overexpression of gene Z increase glucose production? | CRISPR knock-in of a strong promoter |
| How does a tagged protein localize during gluconeogenesis? | Tagged knock-in (e.g., GFP) |
| What is the effect of a natural compound on gluconeogenic genes? | CRISPR library screening |
| Is the regulation conserved in other species? | Ovine skeletal muscle cells |
How to Study the regulation of gluconeogenesis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | mRNA levels of gluconeogenic genes | Transcriptional regulation studies |
| ChIP-seq | Transcription factor binding to gluconeogenic promoters | Epigenetic regulation |
| Proteomics | Protein abundance and modifications | Posttranslational regulation |
| Metabolic flux analysis | Glucose production rate | Functional validation |
| CRISPR screen | Gene essentiality for gluconeogenesis | Discovery of novel regulators |
| qPCR | Expression of key enzymes | Rapid screening |
| Western blot | Protein levels of PCK1, G6PC | Validation of regulation |
Transcriptomic analysis (RNA-seq)
RNA-seq measures changes in mRNA levels of gluconeogenic genes under different hormonal or nutritional conditions, revealing transcriptional regulation.
Proteomics and posttranslational modification analysis
Mass spectrometry-based proteomics identifies acetylation and other modifications on metabolic enzymes, linking posttranslational control to gluconeogenesis.
Metabolic flux analysis
Isotope tracing and flux analysis quantify glucose production from noncarbohydrate precursors, directly assessing gluconeogenic rate.
CRISPR screening and functional genomics
Genome-wide CRISPR screens identify novel regulators of gluconeogenesis, enabling unbiased discovery of genes and pathways.
How CRISPR Can Be Used to Study GO:0006111 regulation of gluconeogenesis
Knockout
CRISPR knockout of candidate regulators (e.g., PCK1, PPARGC1A) in liver cell lines or primary hepatocytes can determine whether they are required for gluconeogenesis.
Point Mutation
Introducing disease-associated point mutations (e.g., in G6PC) via CRISPR allows study of their impact on enzyme activity and gluconeogenic flux.
Knock-in
Knock-in of tagged versions of gluconeogenic enzymes (e.g., GFP-PCK1) enables live-cell imaging and localization studies.
Overexpression
CRISPR activation or knock-in of strong promoters can overexpress regulators like PGC-1alpha to assess their sufficiency in driving gluconeogenesis.
How EDITGENE Supports regulation of gluconeogenesis Research
Researchers studying regulation of gluconeogenesis-related genes often need to determine whether a candidate gene is causally involved in glucose production, and CRISPR-based models provide a direct way to test this. EDITGENE offers a comprehensive suite of services to generate precisely engineered cell models for such studies.
Contact EDITGENE today to design your custom CRISPR model for regulation of gluconeogenesis research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| TCF7L2 Knockout HEK293 Cell Line | EDJ-KQ340 | Human | 6934 | Details Get a Quote |
| SIRT6 Knockout HEK293 Cell Line | EDJ-KQ948 | Human | 51548 | Details Get a Quote |
| DGKQ Knockout HEK293 Cell Line | EDJ-KQ1698 | Human | 1609 | Details Get a Quote |
| FBP1 Knockout HEK293 Cell Line | EDJ-KQ1863 | Human | 2203 | Details Get a Quote |
| CRY1 Knockout HEK293 Cell Line | EDJ-KQ3045 | Human | 1407 | Details Get a Quote |
| ACADM Knockout HEK293 Cell Line | EDJ-KQ3144 | Human | 34 | Details Get a Quote |
| PDK2 Knockout HEK293 Cell Line | EDJ-KQ3278 | Human | 5164 | Details Get a Quote |
| GNMT Knockout HEK293 Cell Line | EDJ-KQ8723 | Human | 27232 | Details Get a Quote |
| SELENOS Knockout HEK293 Cell Line | EDJ-KQ12002 | Human | 55829 | Details Get a Quote |
| SDHAF3 Knockout HEK293 Cell Line | EDJ-KQ15207 | Human | 57001 | Details Get a Quote |
| SIRT7 Knockout HEK293 Cell Line | EDJ-KQ15266 | Human | 51547 | Details Get a Quote |
| ZNF692 Knockout HEK293 Cell Line | EDJ-KQ16328 | Human | 55657 | Details Get a Quote |
| TCF7L2 Knockout HeLa Cell Line | EDJ-KQ17974 | Human | 6934 | Details Get a Quote |
| SIRT7 Knockout A-549 Cell Line | EDJ-KQ18097 | Human | 51547 | Details Get a Quote |
| SIRT6 Knockout A-549 Cell Line | EDJ-KQ19936 | Human | 51548 | Details Get a Quote |
- 1
- 2
- Next Page »
Frequently Asked Questions About regulation of gluconeogenesis
What is GO:0006111 regulation of gluconeogenesis?
GO:0006111 is a Gene Ontology biological process term defined as any process that modulates the frequency, rate or extent of gluconeogenesis, the formation of glucose from noncarbohydrate precursors such as pyruvate, amino acids and glycerol.
What genes are involved in regulation of gluconeogenesis?
Key genes include PCK1, G6PC, PPARGC1A, FOXO1, CREB, NR3C1, SIRT1, and EP300, among others.
How do glucocorticoids regulate gluconeogenesis?
Glucocorticoids such as cortisol activate transcription of gluconeogenic enzymes and coactivators, increasing glucose production during fasting.
What is the role of PGC-1alpha in gluconeogenesis?
PGC-1alpha is a transcriptional coactivator that drives expression of gluconeogenic genes and is a master regulator of metabolic adaptation.
Can natural compounds regulate gluconeogenesis?
Yes, flavonoids and other natural small molecules can modulate gluconeogenesis at pretranslational and posttranslational levels.
How is gluconeogenesis regulated in cancer?
Cancer cells often upregulate gluconeogenesis to support growth, and its regulation is reprogrammed to meet metabolic demands.
What experimental models are used to study regulation of gluconeogenesis?
Common models include liver cell lines, primary hepatocytes, knockout mice, and CRISPR-engineered cells.
What is the difference between gluconeogenesis and glycolysis?
Gluconeogenesis synthesizes glucose from noncarbohydrate precursors, while glycolysis breaks down glucose; they are reciprocally regulated.
How does insulin regulate gluconeogenesis?
Insulin suppresses gluconeogenesis by inhibiting transcription of gluconeogenic genes and promoting glucose storage.
What are the key enzymes of gluconeogenesis?
Key enzymes include PCK1, G6PC, FBP1, and PC, which catalyze irreversible steps.
Conclusion
GO:0006111 regulation of gluconeogenesis is a fundamental biological process that integrates hormonal, nutritional, and epigenetic signals to control glucose production. Its dysregulation underlies major metabolic diseases, making it a prime target for therapeutic intervention. CRISPR-based models and functional genomics offer powerful tools to dissect its regulatory network and identify new drug targets.
References
- 1. Kuo T et al.. 2015. Regulation of Glucose Homeostasis by Glucocorticoids.. Adv Exp Med Biol 872:99-126 PMID: 26215992
- 2. Han HS et al.. 2016. Regulation of glucose metabolism from a liver-centric perspective.. Exp Mol Med 48(3):e218 PMID: 26964834
- 3. Exton JH. 1979. Regulation of gluconeogenesis by glucocorticoids.. Monogr Endocrinol 12:535-46 PMID: 386091
- 4. Wu X et al.. 2023. Advances in Small Molecules of Flavonoids for the Regulation of Gluconeogenesis.. Curr Top Med Chem 23(23):2214-2231 PMID: 37496138
- 5. Zhao S et al.. 2010. Regulation of cellular metabolism by protein lysine acetylation.. Science 327(5968):1000-4 PMID: 20167786
- 6. Hatano R et al.. 2024. Hepatic ketone body regulation of renal gluconeogenesis.. Mol Metab 84:101934 PMID: 38604598
- 7. Wu X et al.. 2023. Advances in natural small molecules on pretranslational regulation of gluconeogenesis.. Drug Dev Res 84(4):613-628 PMID: 36988114
- 8. Pang Y et al.. 2024. Expression Regulation of Gluconeogenesis Related Genes in Ovine Skeletal Muscle Cells.. Front Biosci (Landmark Ed) 29(6):237 PMID: 38940053
